Evelo Biosciences, Inc.

MORGAN STANLEY EVLO

Report date

3/31/2023

Quarter

2023 Q1

Filed

5/15/2023

Shares

58,612

Value ($000)

11

Weight

0.0%

2019 Q4 - 2023 Q1 (14 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2023 Q1	5/15/2023	11	0.0%	58,612	3/31/2023
2022 Q4	2/14/2023	127	0.0%	78,892	12/31/2022
2022 Q3	11/14/2022	134	0.0%	64,325	9/30/2022
2022 Q2	10/27/2022	294	0.0%	139,563	6/30/2022
2022 Q1	10/27/2022	171	0.0%	50,294	3/31/2022
2021 Q4	2/14/2022	306	0.0%	50,436	12/31/2021
2021 Q3	11/15/2021	564	0.0%	80,144	9/30/2021
2021 Q2	8/23/2021	732	0.0%	53,220	6/30/2021
2021 Q1	5/17/2021	728	0.0%	68,020	3/31/2021
2020 Q4	2/16/2021	1,107	0.0%	91,628	12/31/2020
2020 Q3	11/13/2020	279	0.0%	52,772	9/30/2020
2020 Q2	8/14/2020	231	0.0%	47,251	6/30/2020
2020 Q1	5/26/2020	175	0.0%	46,626	3/31/2020
2019 Q4	2/14/2020	223	0.0%	54,807	12/31/2019